ABEO (Abeona Therapeutics) Net Profit

Abeona Therapeutics (ABEO) focuses on developing innovative medicines to combat orphan diseases. The business relies on the synergy of scientists united by the goal of saving children, which ensures the team's dedication. The current figure is -0.06. This price action chart demonstrates the impact of concerns regarding FDA delays and a shortage of laboratory resources on the issuer's quotes.

Abeona Therapeutics (ABEO) is investing in costly drug development and the environmental modernization of its production facilities. This indicator of the company's financial success reflects the trend of net income adjusted for one-time operations. The metric measures the actual speed of cash generation, allowing for the identification of a gap between the market price and the actual business return. A steady decline in profit amid rising quotes signals the risk of an investment bubble. The asset belongs to the high-risk biotechnology sector.